Vaccines

>

Latest News

FDA Places Clinical Hold on Novavax Combination COVID-19–Influenza Vaccine Application
FDA Places Clinical Hold on Novavax Combination COVID-19–Influenza Vaccine Application

October 16th 2024

A serious adverse event of motor neuropathy reported in September 2024 has resulted in a hold on the investigational new drug application.

GSK's Arexvy Vaccine Demonstrates Strong Efficacy Against RSV in Older Adults
GSK's Arexvy Vaccine Demonstrates Strong Efficacy Against RSV in Older Adults

October 9th 2024

Phase 2/3 Trial of New Omicron-Targeted Vaccine Shows Efficacy in Adolescents
Phase 2/3 Trial of New Omicron-Targeted Vaccine Shows Efficacy in Adolescents

September 30th 2024

Though MMR Vaccine Remains Highly Protective Against Measles, Some Waning Immunity Can Lead to Outlier Cases
Though MMR Vaccine Remains Highly Protective Against Measles, Some Waning Immunity Can Lead to Outlier Cases

September 26th 2024

NFID Survey: Fewer Than 1 in 5 Americans Are Concerned About Respiratory Viruses
NFID Survey: Fewer Than 1 in 5 Americans Are Concerned About Respiratory Viruses

September 26th 2024

<1
...
3435363738
© 2024 MJH Life Sciences

All rights reserved.